Check out this morning’s view in #Boston ! Stay tuned for on-site coverage of ACP #IM2024 .

hcplive.com/conference/acp

Data presented at #ISNWCN showed oral targeted-release budesonide capsule (Nefecon) was linked to preserved eGFR status and kidney failure risk, as well as maintained quality of life, in patients with #IgAN .

Read the phase 3 #nephrology findings here:

hcplive.com/view/budesonid…

State-of-the-art large language models, including GPT-4, are approaching expert-level clinical knowledge and reasoning in #Ophthalmology .

Read more: hcplive.com/view/gpt-4-nea…

Results of the SELECT-GCA study showed approximately half of patients with giant cell arteritis treated with #upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52.

hcplive.com/view/phase-3-u…
#RheumTwitter

Join APAC for only $80 (cardiologypa.org/join-apac) and CAPP registration is INCLUDED! Current APAC members can attend CAPP for FREE!

Early registration for non-member PA/NPs is currently $200 and this rate increases on 6/2. capplive.org

ICYMI: The US FDA approved of the #ustekinumab (Stelara) #biosimilar , ustekinumab-aekn (Selardsi), for the treatment of moderate to severe plaque #psoriasis and active #PsoriaticArthritis .

Learn more:
hcplive.com/view/fda-appro…

Our team is ready to get started covering ACP #IM2024 in Boston this week!

We we will be covering so many presentations and new data at the conference, and we look forward to some great interviews.

Stay up to date by following HCPLive.

hcplive.com/latest-confere…

A new analysis identified an association between visual impairment and an elevated risk of suicide, with age serving as a predictive factor.

Read more here:👇
hcplive.com/view/visual-im…
#ophthalmology

Findings from Kidney CHAMP suggest a multifaceted electronic health record and population health management strategy may help address barriers to the implementation of evidence-based #CKD care.

Learn more:
hcplive.com/view/electroni…

Check out an interview with one of the lead investigators of the #EMERGENT trials, Rishi Kakar, MD, who discussed the promising 52-week data of #KarXT .

hcplive.com/view/insight-o…

Topline data from the SURMOUNT-OSA studies provide insight into the effects of tirzepatide in OSA with obesity, with Lilly disclosing plans for a regulatory submission mid-year.

hcplive.com/view/tirzepati…

#Obesity #SleepHealth

As we head to Boston, our team is ready to get started covering ACP #IM2024 !

We we will be covering so many presentations and new data at the conference, and we look forward to great interviews.

Stay up to date by following HCPLive.

hcplive.com/latest-confere…

Participants with #RheumatoidArthritis and #Osteoarthritis described a plant-based diet intervention as complete and coherent and would recommend this intervention to other patients.

Learn more:
hcplive.com/view/plant-bas…

Could we see a new indication for tirzepatide before end of 2024?

With topline results from SURMOUNT-OSA announced this AM, Eli Lilly and Company disclosed plans to submit these data to regulatory bodies in the US and abroad beginning mid-year.

hcplive.com/view/tirzepati…
#SleepApnea

EULAR’s #fibromyalgia guidelines provide comprehensive recommendations for managing active fibromyalgia to assist clinicians in making informed decisions.

Test your knowledge with this quiz: hcplive.com/view/clinical-…

Have you checked out our YouTube channel?

We just dropped the latest HCPLive Five, a rundown of top news from #ACC24 , featuring in-depth KOL insight on all things #cardiology from this year's meeting.

Watch and subscribe here: youtube.com/watch?v=FSIv3K…

Hear from Jonathan Barratt about findings from subgroup analyses of the phase 3 PROTECT trial of sparsentan versus irbesartan in adult patients with primary IgA nephropathy, presented at #ISNWCN .

hcplive.com/view/jonathan-…

ICYMI: What is the impact of smoking cigarettes on #psoriasis improvements?

In a new study by investigators in China highlights the impact of being a current or former smoker on #PASI75 outcomes.

View here: hcplive.com/view/psoriasis…

Among children with #chronic medical conditions, those with #sleep disorders have nearly twice the odds of health care utilization compared to those without sleep disorders, a new study found.

hcplive.com/view/children-…

From #ACC24 : BALANCE trial data suggest olezarsen could prove useful in management of FCS.

Learn more: hcplive.com/view/olezarsen…

#Cardiology